Stocks News

LAST PRICE
1.4800
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
1.4500/ 1
Ask / Lots
1.6100/ 1
Open / Previous Close
0.0000 / 1.4800
Day Range
---
52 Week Range
Low 1.1000
High 5.9000
Volume
---
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

May 29, 2024
- Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference, from 7:00AM ET on Wednesday May 29, 2024 by Business Wire
  7:00AM ET on Wednesday May 29, 2024 by Business Wire
  Companies Mentioned: ACET
  Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference being held from June 5-6, 2024 in New York.
- Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference, from 7:00AM ET on Wednesday May 29, 2024 by Dow Jones
  7:00AM ET on Wednesday May 29, 2024 by Dow Jones
  Companies Mentioned: ACET
  REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--May 29, 2024--
  Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference being held from June 5-6, 2024 in New York.
May 15, 2024
- DJ Adicet Bio Price Target Maintained With a $10.00/Share by HC Wainwright & Co., from 12:56PM ET on Wednesday May 15, 2024 by Dow Jones
  12:56PM ET on Wednesday May 15, 2024 by Dow Jones
  Companies Mentioned: ACET
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ACET/analyst-ratings
  
  (END) Dow Jones Newswires
  
  May 15, 2024 12:56 ET (16:56 GMT)
May 14, 2024
- Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates, from 4:01PM ET on Tuesday May 14, 2024 by Business Wire
  4:01PM ET on Tuesday May 14, 2024 by Business Wire
  Companies Mentioned: ACET
  --Presented promising preclinical data on ADI-270 at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting; on track to file investigational new drug (IND) in renal cell carcinoma in 2Q 2024
- Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates, from 4:01PM ET on Tuesday May 14, 2024 by Dow Jones
  4:01PM ET on Tuesday May 14, 2024 by Dow Jones
  Companies Mentioned: ACET
  
  On track to initiate Phase 1 clinical trial evaluating ADI-001 in lupus nephritis in 2Q 2024
  
  Presented promising preclinical data on ADI-270 at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting; on track to file investigational new drug (IND) in renal cell carcinoma in 2Q 2024

Yesterday
- Vigil Neuroscience to Present in Upcoming June Investor Conferences, from 7:05AM ET on Thursday May 30, 2024 by GlobeNewswire
  7:05AM ET on Thursday May 30, 2024 by GlobeNewswire
  Companies Mentioned: VIGL
May 29, 2024
- Citius Pharmaceuticals to Host Investor Call to Discuss Topline Results of Phase 3 Trial of Mino-Lok Antibiotic Lock Solution, from 8:30AM ET on Wednesday May 29, 2024 by PR Newswire
  8:30AM ET on Wednesday May 29, 2024 by PR Newswire
  Companies Mentioned: CTXR
May 24, 2024
- aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:00PM ET on Friday May 24, 2024 by GlobeNewswire
  4:00PM ET on Friday May 24, 2024 by GlobeNewswire
  Companies Mentioned: LIFE
May 21, 2024
- Citius Pharmaceuticals Achieves Primary and Secondary Endpoints in Phase 3 Trial of Mino-Lok Antibiotic Lock Solution, from 7:00AM ET on Tuesday May 21, 2024 by PR Newswire
  7:00AM ET on Tuesday May 21, 2024 by PR Newswire
  Companies Mentioned: CTXR
May 16, 2024
- Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference, from 8:30AM ET on Thursday May 16, 2024 by GlobeNewswire
  8:30AM ET on Thursday May 16, 2024 by GlobeNewswire
  Companies Mentioned: NVCT
May 15, 2024
- aTyr Pharma to Present Poster Describing Efzofitimod's Mechanism of Action at the American Thoracic Society 2024 International Conference, from 7:00AM ET on Wednesday May 15, 2024 by GlobeNewswire
  7:00AM ET on Wednesday May 15, 2024 by GlobeNewswire
  Companies Mentioned: LIFE
May 14, 2024
- Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2024 Financial Results and Provides Business Update, from 4:05PM ET on Tuesday May 14, 2024 by PR Newswire
  4:05PM ET on Tuesday May 14, 2024 by PR Newswire
  Companies Mentioned: CTXR
- aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT(TM) Study in Pulmonary Sarcoidosis, from 8:00AM ET on Tuesday May 14, 2024 by GlobeNewswire
  8:00AM ET on Tuesday May 14, 2024 by GlobeNewswire
  Companies Mentioned: LIFE
May 10, 2024
- Citius Pharmaceuticals to Participate in Upcoming EF Hutton and H.C. Wainwright Investor Conferences, from 8:30AM ET on Friday May 10, 2024 by PR Newswire
  8:30AM ET on Friday May 10, 2024 by PR Newswire
  Companies Mentioned: CTXR
May 8, 2024
- Vigil Neuroscience to Present at The Citizens JMP Life Sciences Conference, from 7:40AM ET on Wednesday May 08, 2024 by GlobeNewswire
  7:40AM ET on Wednesday May 08, 2024 by GlobeNewswire
  Companies Mentioned: VIGL

Adicet Bio Inc
NASDAQ:ACETUnited States

Search Criteria

May 29, 2024

Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference, from 7:00AM ET on Wednesday May 29, 2024 by Business Wire

Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference, from 7:00AM ET on Wednesday May 29, 2024 by Dow Jones

May 15, 2024

DJ Adicet Bio Price Target Maintained With a $10.00/Share by HC Wainwright & Co., from 12:56PM ET on Wednesday May 15, 2024 by Dow Jones

May 14, 2024

Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates, from 4:01PM ET on Tuesday May 14, 2024 by Business Wire

Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates, from 4:01PM ET on Tuesday May 14, 2024 by Dow Jones

Peers Headlines

Yesterday

Vigil Neuroscience to Present in Upcoming June Investor Conferences, from 7:05AM ET on Thursday May 30, 2024 by GlobeNewswire

May 29, 2024

Citius Pharmaceuticals to Host Investor Call to Discuss Topline Results of Phase 3 Trial of Mino-Lok Antibiotic Lock Solution, from 8:30AM ET on Wednesday May 29, 2024 by PR Newswire

May 24, 2024

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:00PM ET on Friday May 24, 2024 by GlobeNewswire

May 21, 2024

Citius Pharmaceuticals Achieves Primary and Secondary Endpoints in Phase 3 Trial of Mino-Lok Antibiotic Lock Solution, from 7:00AM ET on Tuesday May 21, 2024 by PR Newswire

May 16, 2024

Nuvectis Pharma, Inc. to Present at the H.C. Wainwright BioConnect Investor Conference, from 8:30AM ET on Thursday May 16, 2024 by GlobeNewswire

May 15, 2024

aTyr Pharma to Present Poster Describing Efzofitimod's Mechanism of Action at the American Thoracic Society 2024 International Conference, from 7:00AM ET on Wednesday May 15, 2024 by GlobeNewswire

May 14, 2024

Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2024 Financial Results and Provides Business Update, from 4:05PM ET on Tuesday May 14, 2024 by PR Newswire

aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT(TM) Study in Pulmonary Sarcoidosis, from 8:00AM ET on Tuesday May 14, 2024 by GlobeNewswire

May 10, 2024

Citius Pharmaceuticals to Participate in Upcoming EF Hutton and H.C. Wainwright Investor Conferences, from 8:30AM ET on Friday May 10, 2024 by PR Newswire

May 8, 2024

Vigil Neuroscience to Present at The Citizens JMP Life Sciences Conference, from 7:40AM ET on Wednesday May 08, 2024 by GlobeNewswire